Table 2. Median (interquartile) of the hormones and lipid profile in women with polycystic ovary syndrome and controls.

Variable	Cases (n=55)	Controls (n=55)	P-value
Thyroid-stimulating hormone (mIU/mL)	2.48 (1.65–3.71)	2.08 (1.47–3.39)	0.424
Free tri-iodothyronine (pg/mL)a)	3.50±0.2	3.38±0.3	0.040
Free thyroxine (ng/dL)a)	1.28±0.1	1.29±0.1	0.897
Follicle stimulating hormone (IU/L)	8.4 (6.0–11.3)	8.3 (6.3–10.3)	0.423
Luteinizing hormone (IU/L)	7.7 (4.6–10.0)	6.9 (4.05–9.0)	0.303
Luteinizing hormone/follicle stimulating hormone	0.78 (0.5–1.3)	0.81 (0.45–1.36)	0.347
Prolactin (mIU/L)	12.0 (9.7–18.0)	13.80 (10.7–21.0)	0.212
Testosterone (ng/dL)	82.0 (76.0–91.0)	85.0 (75.50–3.0)	0.591
Anti-thyroid peroxidase (IU/mL)	20.0 (16.00–23.0)	20.0 (17.00–33.0)	0.285
Anti-thyroglobulin (IU/mL)	26.0 (21.0–32.0)	23.0 (21.0 –29.5)	0.262
Cholesterol (mg/dL)	200.0 (179.0–214.0)	197.0 (172.0–203.0)	0.100
Triglycerides (mg/dL)	148.0 (100.0–187.0)	123.0 (97.00–166.0)	0.129
High density lipoprotein (mg/dL)	37.0 (34.0–42.0)	35.80 (29.0–41.0)	0.015
low density lipoprotein (mg/dL)	142.0 (123.0–150.0)	132.0 (111.0–145.0)	0.062

^a)Mean±standard deviation and t-test was used.